Theracryf (TCF) Competitors GBX 0.27 +0.05 (+20.00%) As of 05/2/2025 10:57 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsBuy This Stock TCF vs. STL, HWC, AGM, FCRM, SFE, ABTX, PGY, STEL, TCA, and CHOCShould you be buying Theracryf stock or one of its competitors? The main competitors of Theracryf include Stilo International (STL), Highway Capital (HWC), Applied Graphene Materials (AGM), Fulcrum Utility Services (FCRM), Safestyle UK (SFE), ABTX.L (ABTX), Progility (PGY), Stellar Diamonds (STEL), Terra Capital (TCA), and United Cacao Limited SEZC (CHOC). These companies are all part of the "banking" industry. Theracryf vs. Stilo International Highway Capital Applied Graphene Materials Fulcrum Utility Services Safestyle UK ABTX.L Progility Stellar Diamonds Terra Capital United Cacao Limited SEZC Theracryf (LON:TCF) and Stilo International (LON:STL) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, dividends, valuation, profitability, community ranking, media sentiment and analyst recommendations. Does the MarketBeat Community prefer TCF or STL? Stilo International received 109 more outperform votes than Theracryf when rated by MarketBeat users. CompanyUnderperformOutperformTheracryfN/AN/AStilo InternationalOutperform Votes10968.13% Underperform Votes5131.88% Is TCF or STL more profitable? Stilo International has a net margin of 0.00% compared to Theracryf's net margin of -792.17%. Stilo International's return on equity of 0.00% beat Theracryf's return on equity.Company Net Margins Return on Equity Return on Assets Theracryf-792.17% -99.97% -48.26% Stilo International N/A N/A N/A Does the media refer more to TCF or STL? In the previous week, Theracryf had 1 more articles in the media than Stilo International. MarketBeat recorded 1 mentions for Theracryf and 0 mentions for Stilo International. Theracryf's average media sentiment score of 0.00 equaled Stilo International'saverage media sentiment score. Company Overall Sentiment Theracryf Neutral Stilo International Neutral Do institutionals and insiders believe in TCF or STL? 37.0% of Theracryf shares are held by institutional investors. 42.9% of Theracryf shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has preferable earnings and valuation, TCF or STL? Stilo International has higher revenue and earnings than Theracryf. Theracryf is trading at a lower price-to-earnings ratio than Stilo International, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTheracryf£687.67K1.87-£5.45M-£1.03-0.26Stilo International£1.42M0.00N/A£0.10N/A SummaryStilo International beats Theracryf on 7 of the 10 factors compared between the two stocks. Get Theracryf News Delivered to You Automatically Sign up to receive the latest news and ratings for TCF and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TCF vs. The Competition Export to ExcelMetricTheracryfBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£1.29M£125.57M£5.56B£2.64BDividend YieldN/A3.69%5.36%4.81%P/E Ratio-0.263.2722.79134.53Price / Sales1.874,272.58406.35243,421.56Price / CashN/A13.0238.1828.36Price / Book0.3234.206.794.53Net Income-£5.45M-£90.45M£3.23B£5.90B7 Day Performance9.31%1.33%3.36%3.50%1 Month Performance28.57%7.35%11.23%8.87%1 Year PerformanceN/A94.88%16.78%26.32% Theracryf Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TCFTheracryfN/AGBX 0.27+20.0%N/AN/A£1.29M£687,674.98-0.2610News CoverageSTLStilo InternationalN/AN/AN/AN/A£3.42M£1.42M30.001,907Gap UpHWCHighway CapitalN/AN/AN/AN/A£1.78MN/A0.003,630Gap UpAGMApplied Graphene MaterialsN/AN/AN/AN/A£643,000.00£127,000.00-20.00160Gap DownFCRMFulcrum Utility ServicesN/AN/AN/AN/A£599,000.00£50.55M-3.0050Gap DownSFESafestyle UKN/AN/AN/AN/A£444,000.00£150.18M-4.5718,500ABTXABTX.LN/AN/AN/AN/A£0.00N/A0.00590High Trading VolumePGYProgilityN/AN/AN/AN/A£0.00N/A0.00800Gap DownHigh Trading VolumeSTELStellar DiamondsN/AN/AN/AN/A£0.00N/A0.001,020Gap UpTCATerra CapitalN/AN/AN/AN/A£0.00N/A0.002,200CHOCUnited Cacao Limited SEZCN/AN/AN/AN/A£0.00N/A0.00N/A Related Companies and Tools Related Companies STL Competitors HWC Competitors AGM Competitors FCRM Competitors SFE Competitors ABTX Competitors PGY Competitors STEL Competitors TCA Competitors CHOC Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:TCF) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Theracryf Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Theracryf With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TCF Stock Free TCF Stock Alerts